首页> 美国卫生研究院文献>Frontiers in Medicine >YF-H-2015005 a CXCR4 Antagonist for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized Controlled Phase 3 Clinical Trial

【2h】

YF-H-2015005 a CXCR4 Antagonist for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized Controlled Phase 3 Clinical Trial

机译：CXCR4拮抗剂YF-H-2015005用于在非霍奇金淋巴瘤患者中动员造血干细胞：随机受控第3期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Frontiers in Medicine
作者
Weiping Liu; Yufu Li; Quanshun Wang; Hang Su; Kaiyang Ding; Yuerong Shuang; Sujun Gao; Dehui Zou; Hongmei Jing; Ye Chai; Yicheng Zhang; Lihong Liu; Chunling Wang; Hui Liu; Jinying Lin; Haiyan Zhu; Chen Yao; Xiaoyan Yan; Meixia Shang; Shufang Wang; Fengyuan Chang; Xiaopei Wang; Jun Zhu; Yuqin Song;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类情报学;
关键词
hematopoietic stem cell mobilization; therapeutics; treatment outcome; safety; lymphoma; non-Hodgkin;

机译：造血干细胞动员;治疗结果;治疗结果;安全;淋巴瘤;非霍奇金;

相似文献

外文文献
中文文献
专利

1. YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial [J] . Weiping Liu, Ye Chai, Yicheng Zhang, Frontiers in Medicine . 2021,第a期

机译：CXCR4拮抗剂YF-H-2015005，用于在非霍奇金淋巴瘤患者中动员造血干细胞：随机，受控，第3期临床试验
2. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. [J] . DiPersio JF, Micallef IN, Stiff PJ Journal of Clinical Oncology . 2009,第28期

机译：与非安慰剂加粒细胞集落刺激因子相比，对于非霍奇金淋巴瘤患者自体干细胞动员和移植，普乐沙福加粒细胞集落刺激因子与安慰剂加粒细胞集落刺激因子的三期前瞻性随机双盲安慰剂对照试验。
3. Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study [J] . Zhu Jun, Huang Huiqiang, Chen Huan, Transfusion: The Journal of the American Association of Blood Banks . 2018,第1期

机译：Plerixafor和粒细胞 - 菌落刺激因子用于动员造血干细胞，用于中国非霍奇金淋巴瘤患者的自体移植：随机第3研究
4. A clinical trial of prophylactic antifungal therapy in patients undergoing hematopoietic stem cell transplantation [C] . Zhou Qi, Lou Fangding, Zhang Bolong Proceedings of the Fourth China-Jpan international congress of mycology . 1998

机译：造血干细胞移植患者预防性抗真菌治疗的临床试验
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Clinical Trials and Observations: Total body irradiation etoposide cyclophosphamide and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438) [O] . John A. Thompson, Richard I. Fisher, Michael LeBlanc, -1

机译：临床试验和观察：全身照射依托泊苷环磷酰胺和自体外周血干细胞移植随后随机分配白介素-2治疗与非霍奇金淋巴瘤患者观察：西南大学一项3期随机试验的结果肿瘤学小组（SWOG 9438）
7. YF-H-2015005, a CXCR4 Antagonist, for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized, Controlled, Phase 3 Clinical Trial [O] . Weiping Liu, Yufu Li, Quanshun Wang, 2021

机译：CXCR4拮抗剂YF-H-2015005，用于在非霍奇金淋巴瘤患者中动员造血干细胞：随机，受控，第3期临床试验

YF-H-2015005 a CXCR4 Antagonist for the Mobilization of Hematopoietic Stem Cells in Non-Hodgkin Lymphoma Patients: A Randomized Controlled Phase 3 Clinical Trial

著录项

相似文献

相关主题

期刊订阅